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The occurrence of extensive antibiotics resistant bacteria increased the demands
for mining out new sources of antimicrobial agents. Actinomycetes, especially
Streptomyces sp. have grasped considerable attention worldwide due to production
of many useful bioactive metabolites. In the present study, a total of 52 actinomycetes
were isolated from agricultural soil samples in Beni-Suef, Egypt. All isolates were
characterized based on colony morphology, mycelium coloration, and pigment diffusion.
They were screened for their capabilities to show antimicrobial activities against different
indicator microorganisms, and only 20 isolates have shown significant antimicrobial
activities against at least one of the tested indicator microorganisms. The isolate
AGM12-1 was active against all tested microorganisms and showed a marked antitumor
activity with IC50 3.3 and 1.1 µg/ml against HCT-116 and HepG-2 cell lines respectively.
It was genotypically characterized as Streptomyces sp. with the presence of PKS 5
biosynthetic gene cluster. Mannitol, ammonium sulfate, pH 7, 2% inoculum size and
incubation for 11 days at 30◦C were the optimum conditions that used to maximize
the production and hence allowed purification of one active antimicrobial compound
to homogeneity using high performance liquid chromatography with a molecular mass
of m/z 488.05. Nuclear magnetic resonance structural elucidation showed that this
compound was a diketopiperazine derivative.
Keywords: actinomycetes, antimicrobial, antitumor, diketopiperazine, Streptomyces sp., Streptomyces
vinaceusdrappus
INTRODUCTION
Actinomycetes are Gram-positive filamentous bacteria with fungal morphology. They are
characterized by a complicated life cycle belonging to the phylum Actinobacteria (Dilip et al.,
2013). They are widely distributed in terrestrial ecosystems, especially in soil, where they play a
pivotal role in recycling of industrial wastes and biomaterials by decomposing complex polymeric
structures in dead plants, animals, and fungal materials (Goodfellow and Williams, 1983).
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Actinobacteria, especially Streptomyces sp. are known as
noble factories for the production of many biologically active
compounds that are useful as antibacterials, antifungals,
antivirals, antithrombotics, immunomodifiers, anti-tumor drugs,
and enzyme inhibitors in many fields especially in medicine
(Sacramento et al., 2004; Atta, 2009; Fukuchi et al., 2009;
Olano et al., 2009; Ser et al., 2015). Due to the emergence
of multi-resistant microorganisms to almost all available
antibiotics, many researchers are focused now on discovering
novel antimicrobials from many natural resources such as
those produced by actinomycetes especially those isolated
from many undiscoverable or poorly explored environments
(Undabarrena et al., 2016). These antimicrobials are produced
by many metabolic pathways, mainly organized by polyketide
synthases (PKS) and non-ribosomal peptide synthetases (NRPS)
(Undabarrena et al., 2016). Incidence and presence of these
biosynthetic genes in actinobacteria are obviously high (Donadio
et al., 2007).
Egyptian soil reservoir is considered as a poorly investigated
source for actinobacteria, and very few reports were published
(Hozzein and Goodfellow, 2007; Awad et al., 2009; Abd-Alla
et al., 2013; Rifaat et al., 2013). In these perspectives, the present
study aimed to isolate and characterize different actinomycetes
from soil niche in Beni-Suef governorate, Egypt. Actinomycetes
were screened for their capabilities to produce antimicrobial and
antitumor active metabolites. The bioactive compound from the
most potent isolate was further purified and characterized.
MATERIALS AND METHODS
Collection of Samples and Isolation of
Actinomycetes
A number of 13 agricultural soil samples were collected
aseptically from four different sites located in Egypt (Beni-
Suef City, Beba City, Ehnasia City, and El-Fayum roads) from
the upper 15 cm layer of soil using sterile plastic bags and
transported to the laboratory for further isolation steps. Isolation
of actinomycetes was managed using soil dilution plate technique
(Williams et al., 1983) on starch nitrate agar (SNA) and tryptone
soya agar (TSA) supplemented with Rifampicin (10 µg/ml)
and Nystatin (50 µg/ml) to inhibit any bacterial or fungal
contaminants. Briefly, 1 g of each soil sample was diluted with
9 ml of 0.9% saline, homogenized and then a serial dilution
up to 10−4 was carried out. A 100 µl from 10−2, 10−3, and
10−4 dilutions were spread on SNA and TSA, and incubated
at 30◦C for 7 days. Suspected colonies of actinomycetes were
characterized morphologically (Aghamirian and Ghiasian, 2009;
Reddy et al., 2011), re-purified using streak plate method, and
then stored in 40% glycerol at−80◦C.
Screening of Actinomycetes for their
Antimicrobial Activities
Antimicrobial activities of pure isolates were determined by
agar diffusion method (Williams and Davies, 1965) and double
layer agar method (modified spot on lawn technique) (Thakur
et al., 2007; Dundar et al., 2015), against different indicator
microorganisms; Escherichia coli (ATCC 8739), Staphylococcus
aureus (ATCC 6538), Bacillus subtilis (clinical sample), Candida
albicans (clinical sample), and Sarcina lutea (environmental
sample). In double layer agar method, all pure isolates were spot
inoculated on SNA and incubated at 30◦C for 5 days and then
5 ml of molten TSA seeded with 100 µl overnight culture of
indicator microorganisms were poured on spotted plates and
incubated at 37◦C for 24 h. Antimicrobial activities represented
in zones of inhibitions were examined.
Fermentation and Extraction of
Secondary Metabolites and Total
Proteins
The most potent actinomycetes, showing significant antimicro-
bial activities, were undergoing fermentation. Briefly, actino-
mycetes were sub-cultured in tryptone soya broth (TSB) for
5 days and 2% of starting inoculum was used to inoculate 1 L
of International Streptomyces Project 4 (ISP4) broth in a 2 L
Erlenmeyer flask and then incubated on rotary shaker incubator
(200 RPM) at 30◦C for 7 days. The cell-free supernatant from
each flask was collected after centrifugation at 13,000 g for 20 min
and divided into two portions; one used to extract total secondary
metabolites, and the other used to extract total proteins. For
extraction of total metabolites, a 1:1 v/v ethyl acetate was added to
the cell-free culture supernatant and shacked vigorously for 1 h.
The organic phase was separated and evaporated to dryness using
a rotary evaporator (Romankova et al., 1971; Selvameenal et al.,
2009). Total extract residues were weighed and dissolved in 5 ml
ethyl acetate and kept in a refrigerator at 4◦C. For extraction of
total proteins, an ammonium sulfate was added to the cell-free
culture supernatant in a concentration of 40%. Protein pellets
were collected by centrifugation at 14,000 g for 30 min at 4◦C and
then dissolved in 5 ml distilled water, and kept in a refrigerator
at 4◦C.
In vitro Anti-tumor Cytotoxicity
Both ethyl acetate extracts and total proteins of the most potent
actinomyces isolates with significant antimicrobial activities were
evaluated for their cytotoxicity using tissue culture technique.
HepG2 (hepatocellular carcinoma cell line) and HCT 116 (human
colon carcinoma) were obtained from the Pharmacology Unit,
Cancer Biology Department, National Cancer Institute, Cairo
University, Egypt. Cells were maintained in DMEM medium
with 10% fetal calf serum, sodium pyruvate, 100 U/ml penicillin
and 100 mg/ml streptomycin at 37◦C and 5% CO2 till the
cytotoxicity bioassay was carried out. The potential cytotoxicity
of four samples was tested using the method of Skehan et al.
(1990). Briefly, 100 cells/well were plated onto 96-well dishes
overnight before the treatment with the tested compounds to
allow the attachment of cells to the wall of the plate. Different
concentrations of each tested compound (0, 6.25, 12.5, 25, 50,
100µg/ml) were added to the cell monolayer and triple wells were
used for each individual dose. Monolayer cells were incubated
with the tested agent(s) for 48 h at 37◦C and 5% CO2. At the
end of the incubation period, the cells were fixed and stained
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with sulforhodamine B dissolved in acetic acid. Unbound stain
was removed by washing four times with 1% acetic acid and
the protein-bound dye was extracted with Tris-EDTA buffer.
The absorbance was measured in an ELISA reader. The relation
between surviving fraction and compound concentration was
plotted to get the survival curve of each tumor cell line and the
IC50. The concentration of an agent that causes a 50% growth
inhibition, for each tested agent using each cell line was obtained
from the survival curve (Skehan et al., 1990).
Phenotypic Characterization of AGM12-1
Isolate
The physiological, biochemical, and cultural characteristics of
the talented isolate AGM12-1 which showed broad antimicrobial
and cytotoxic activities were examined in detail. The growth
capability, pigment production, and color of both aerial and
substrate mycelium was determined using different growth
media; ISP-3, ISP-4, ISP-5, Czapek Dox, Sato, nutrient agar
and SNA. The color was determined visually by making a
comparison with chips from the ISCC-NBS centroid color
charts (Williams et al., 1983). The types of spore-bearing
hyphae and spores chain morphology were determined using
direct microscopical examination and the shape of the spore
surface was observed using scanning electron microscope (SEM).
Production of catalase, lecithinase, protease, lipase, pectinase,
amylase, hydrogen sulfide, nitrate reductase, urease, gelatinase,
and melanin besides screening for utilization of different nitrogen
sources (peptone, protease peptone, potassium nitrate, yeast
extract, ammonium sulfate), different carbon sources (starch,
glucose, sucrose, fructose, mannitol) and ability to grow at a wide
range of pH from 5 to 11 were carried out according to Williams
et al. (1983).
Genomic DNA Extraction and
Purification
Genomic DNA extraction was done according to Sinha et al.
(2004) and Aly et al. (2016) with some modifications. Briefly,
a 1.5 ml of culture was centrifuged for 10 min at 3,000 g, the
supernatant was discarded and the pellets were resuspended
in 200 µl spheroblast buffer (10% sucrose, 25 mM Tris pH
8.4, 25 mM EDTA pH 8.0, 2 mg/mL lysozyme and 0.4 mg/ml
RNase A), vortexes and incubated at 37◦C for 10 min until
cell lysis occurred. Then, 50 µl of 5% SDS (lysis buffer 1) and
5 M NaCl (lysis buffer 2) were added, mixed and incubated
at 65◦C for 5 min. A 100 µl neutralizing buffer (60 ml 5 M
Potassium acetate, 11.5 ml glacial acetic acid, and 28.5 ml
dH2O) was then added and put on ice for 5 min before
centrifugation at 18,000 g at 4◦C for 15 min. The supernatant
(approximately 400µl) was transferred to a new tube, mixed with
equal volume of isopropanol, left 5 min at room temperature
FIGURE 1 | In vitro anti-tumor cytotoxicity bioassay. (A) Normal human liver cancer cell line (HepG2) while the effect of three tested concentrations 25, 50,
100 µg/ml of the AGM12-1 extract on the survival percent of HepG-2 are illustrated in (B–D), respectively.
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FIGURE 2 | Anti proliferative effect of total ethyl acetate extract,
produced by AGM12-1, on HCT116 cell lines in vitro (A) and on HepG2
cell lines in vitro (B).
and centrifuged at 18,000 g at room temperature for 15 min
to precipitate the DNA. The resulting pellet was washed with
70% ethanol by centrifugation at 18,000 g at room temperature
for 5 min. The final pellet was air-dried and resuspended
in 50 µl 1x TE buffer pH 8 and stored in the refrigerator
at 4◦C.
PCR Amplification and Sequencing of
16S rRNA Gene
The primers used for amplification of the 16S rRNA gene were
11F: 5′-TAACACATGCAAGTCGAACG-3′ (Birri et al., 2013;
Hong-Thao et al., 2016) and 12R: 5′-AGGGTTGCGCTCGTTG-
3′ (Stackebrandt and Charfreitag, 1990; Isik et al., 2014). PCR
was carried out in 50 µl reaction volume in sterile 200 µl PCR
tube. The PCR reaction mixture consisted of 500 ng genomic
DNA, 10 mM dNTPs mixture, 1 µl (20 uM of each primer),
2.5 units of Taq DNA polymerase enzyme and 10 µl 5x reaction
buffer. The PCR program included template denaturation at 94◦C
(3 min), followed by 34 cycles of denaturing at 94◦C (30 s),
annealing at 56◦C (30 s), and extension at 72◦C (60 s), and
followed by completion of DNA synthesis at 72◦C (5 min).
Primers were removed from the final PCR product prior to
sequencing using QIAquick PCR purification kit (QIAGEN,
Germany). The PCR product of interest was detected and purified
by agarose gel electrophoresis using 1% (w/v) agarose gels with
reference to 1 kbp DNA ladder. DNA was sequenced using
the ABI Prism BigDye terminator sequencing ready reaction
kit version 3.1 and analyzed with the ABI Prism 3100 generic
analyzer.
Sequence Manipulation and
Phylogenetic Analysis
The BLAST facility1 was employed in order to assess the degree
of DNA similarity. Multiple sequence alignment and molecular
phylogeny were evaluated using MEGA7 software (Tamura et al.,
2007).
PCR Screening for Antibiotic
Biosynthetic Gene Clusters
The genomic DNA of AGM12-1 isolate was screened for the
presence of the biosynthetic genes involved in the production of
type I polyketide synthase (PKS I), type II polyketide synthase
(PKS II), NRPS and glycopeptide antibiotics. This was achieved
by PCR amplification of these genes using the following
primers; PKS/K1 F: 5′-TSAAGTCSAACATCCGBCA-3′ and
PKS/M6 R: 5′-CGCAGGTTSCSGTACCAGTA-3′ to amplify the
PKS I gene with expected product size of 1200–1400 bp
(Passari et al., 2015), ARO-PKS-F: 5′-GGCAGCGGITTCGGC
GGITTCCAG-3′ and ARO-PKS-R: 5′-CGITGTTIACIGCG
TAGAACCAGGCG-3′ to amplify the PKS II gene with expected
product size of 492–630 bp (Wood et al., 2007), NRPS/A3
F: 5′-GCSTACSYSATSTACACSTCSGG-3′ and NRPS/A7 R:
5′-SASGTCVCCSGTSGCGTAS-3′ to amplify the NRPS gene
with expected product size of 700 bp (Passari et al., 2015), and
finally oxyB F: 5′-CTGGTCGGCAACCTGATGGAC-3′ and
oxyB R: 5′-CAGGTACCGGATCAGCTCGTC-3′ to amplify
the glycopeptide antibiotic gene with expected product size
of 696 bp (Wood et al., 2007). The PCR program included
template denaturation at 95◦C (5 min), followed by 40 cycles of
denaturing at 95◦C (30 s), annealing for PKS I, PKS II, NRPS and
glycopeptide primers at 55, 64, 59, and 60◦C, respectively (60 s),
extension at 72◦C (2 min), and followed by completion of DNA
synthesis at 72◦C (10 min) (Baker et al., 2003).
Optimization of Antimicrobial Production
In order to maximize the production of secondary metabolites
by the isolate AGM12-1, the effect of different carbon sources;
fructose, glucose, mannitol, starch, and sucrose (20 g/l) in
basal nitrate salt medium were studied (Selvin et al., 2009).
The effect of different nitrogen sources; peptone, yeast extract,
ammonium sulfate, protease peptone, and KNO3 (2 g/l) in
the basal starch salt medium were also studied. The most
effective carbon and nitrogen sources were further used in
different concentrations at (1, 1.5, 2, 2.5, 3 g/100 ml) and
(0.1, 0.15, 0.2, 0.25, 0.3 g/100 ml) respectively. The effects of
cultural conditions like different incubation time (2–14 days),
different starting pH (5, 6, 7, 8, 9, 10, and 11), and different
starting inocula (0.01, 0.1, 2, 5, 10, and 15%) were also
1www.ncbi.nlm.nih.gov/blast
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TABLE 1 | Morphological characters and growth of Streptomyces sp. AGM12-1.
Growth media Growth Color of aerial Color of substrate Diffused Form of spore
mycelium mycelium pigments chain
Sato medium Abundant Light brown Light yellowish brown −ve Rectus
Starch nitrate medium Good Medium gray Light grayish–reddish
brown
−ve Rectus
Czapek dox medium Good Light gray Light yellowish brown −ve Rectus
Nutrient agar Abundant Medium gray Dark grayish yellow −ve Rectus
ISP 3 Good Light grayish–yellowish
brown
Grayish yellow −ve Rectus
ISP 4 Good Light gray Light yellowish brown −ve Rectus
ISP 5 Good Grayish–yellowish brown Pale yellow −ve Rectus
examined (Kadiri and Yarla, 2016). The antimicrobial activity
assay using cup technique against sensitive indicator Sarcina
lutea was managed after each experiment, and zones of
inhibitions were measured after incubation of plates at 37◦C for
24 h.
Fermentation Using Optimized
Conditions and Extraction of the
Antimicrobial Compound
To extract putative antimicrobial compound, a 20 ml of 5 days
sub-cultured broth was inoculated in 2 L Erlenmeyer flasks
containing 1 L of liquid mannitol – ammonium sulfate medium
(tow flasks). These flasks were incubated in a rotary shaker (160
RPM) at 30◦C for 11 days. A 2-L total volume was filtered through
Whatman No. 1 filter. After filtration, the total culture filtrate was
extracted with ethyl acetate in a ratio of (1:1 v/v) and shaken
vigorously in a separating funnel. Then, the organic layer was
collected and the solvent extracts were concentrated to dryness
using rotary evaporator and tested for their antimicrobial activity
against various indicator microorganisms.
Purification by HPLC
The total ethyl acetate extract of AGM12-1 was concentrated and
chromatographed via high performance liquid chromatography
(HPLC) (Dionex Ultimate 3000 model HPLC system at the
faculty of pharmacy, Beni-Suef University) using a Nucleosil
C18 column. Elution was carried out using flow-rate 3 ml/min
of 10–100% acetonitrile in water with total run time 25 min.
A total of 23 fractions, 3 ml each, were collected. Fractions
were concentrated, dried, weighed then dissolved in DMSO
and tested for their antimicrobial activities by spotting on the
lawn of Sarcina lutea, and tested for their minimum inhibitory
concentrations by broth micro-dilution method against various
indicator microorganisms.
Spectroscopic Characterization
The LC-Mass spectrum in positive and negative ion mode was
determined at the faculty of postgraduate studies of advanced
science, Beni-Suef University, Egypt and the nuclear magnetic
resonance (NMR) spectrum was determined at the faculty of
pharmacy, Beni-Suef University, Egypt (El-Hawary et al., 2016).
TABLE 2 | Physiological and biochemical characteristics of AGM12-1
isolate.
Experiment Reaction by AGM12-1
The enzymatic activity
Catalase activity +
Gelatinase activity +++
H2S production −
Urea decomposition ++
Amylase activity +++
Pectinolytic activity +++
Lethinase activity −
Lipase activity −
Nitrate reductase activity −
Carbon source utilization
Starch utilization +++
Glucose utilization ++
Sucrose utilization +
Fructose utilization ++
Mannitol utilization +++
Nitrogen source utilization
Peptone utilization ++
Protease peptone utilization ++
Potassium nitrate utilization +
Yeast extract utilization +
Ammonium sulfate utilization +++
Growth at different pH
pH 5 +
pH 6 +
pH 7 +++
pH 8 ++
pH 9 ++
pH 10 +
pH 11 +
Melanin production −
−, negative; +, weakly positive; ++, moderately positive; +++, highly positive.
Bolded symbols mean: Main experimental category.
RESULTS AND DISCUSSION
The emergence of extensive antibiotics resistant bacteria increa-
sed the demands for finding out new sources of antimicrobial
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FIGURE 3 | Phylogenetic tree of AGM12-1 isolate based on partial 16S rRNA gene sequences. The phylogenetic tree was inferred using the
Neighbor-Joining method (Saitou and Nei, 1987). The distances were computed using the Kimura 2-parameter method (Kimura, 1980) and are in the units of the
number of base substitutions per site. Numbers at nodes indicate percentages of 1000 bootstrap re-samplings, only values above 50% are shown. The analysis
involved 20 nucleotide sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All positions containing gaps and missing data were eliminated. There
were a total of 827 positions in the final dataset. Evolutionary analyses were conducted in MEGA7 (Kumar et al., 2016).
agent. Actinomycetes, especially Streptomyces sp., have grasped
considerable attention worldwide due to the production of many
useful bioactive metabolites. Isolation of these species from
poorly explored habitats could increase the possibility to discover
novel microbial products with new types of activities (Ser et al.,
2016b; Sharma et al., 2016).
Isolation of Actinomycetes and
Screening for their Antimicrobial
Activities
A total of 52 actinomycetes were isolated from agricultural
soil samples collected from different locations in Beni-Suef
Governorate, Egypt. Soil niches were reported to be rich
in many significant actinomycetes (Savic et al., 2007; Tan
et al., 2015). All isolates were characterized based on colony
morphology, mycelium coloration, and pigment diffusion. The
protein and organic extracts of each strain were screened for
antimicrobial activity against different indicator microorganisms.
The organic extracts of 20 (38.46%) out of 52 actinomyces
isolates showed antimicrobial activity against at least one of the
tested indicator microorganisms (Supplementary Tables 1a,b).
This percentage was not surprising because it was reported many
times before that incidence of actinomycetes with antimicrobial
activities from the soil niche was relevant high (Thakur et al.,
2007; Bizuye et al., 2013). In this study, four isolates were
able to exhibit promising broad spectrum activity against all
tested indicator microorganisms especially AGM12-1 isolate.
So, these talented isolates were undergoing batch fermentation
plus extraction of their secondary metabolites for further
assessments.
In vitro Anti-tumor Cytotoxicity
Incessant efforts have been directed at the search for more
effective anti-tumors from natural resources which could be
settled into new therapeutic drugs (Ser et al., 2016a). In this
study, both of protein and organic extracts were screened for anti-
tumor cytotoxicity against human liver cancer cell line (HepG2)
and human colon carcinoma (HCT116). The organic extracts of
20 isolates showed anti-tumor toxicity against both cell lines.
The organic extract of AGM12-1 isolate showed substantial
anti-tumor activity (Figure 1) where the survival fractions
were significantly decreased as the concentration increased
(Figures 2A,B). The IC50 values were reached for all examined
Frontiers in Microbiology | www.frontiersin.org 6 March 2017 | Volume 8 | Article 438
fmicb-08-00438 March 9, 2017 Time: 16:42 # 7
Ahmad et al. Streptomyces Releasing Antimicrobials and Antitumors
TABLE 3 | Different growth conditions of Streptomyces sp. AGM12-1 and
their impacts on antimicrobial agent production measured by inhibition
zones against Sarcina lutea.
Different growth conditions Inhibition zone in
millimeter
Starch 19
Glucose 15
Sucrose 14
Fructose 18
Mannitol 20
Potassium nitrate 19
Peptone 24
Yeast extract 22
Ammonium sulfate 26
Protease peptone 24
Mannitol 1% 26
Mannitol 1.5% 26
Mannitol 2% 28
Mannitol 2.5% 29
Mannitol 3% 28
Ammonium sulfate 0.1% 25
Ammonium sulfate 0.15% 27
Ammonium sulfate 0.2% 29
Ammonium sulfate 0.25% 26
Ammonium sulfate 0.3% 25
pH 5 14
pH 6 15.5
pH 7 22
pH 8 19
pH 9 17
pH 10 16
pH 11 11
Starting inoculum 0.01% NA
Starting inoculum 0.1% NA
Starting inoculum 2% 22
Starting inoculum 5% 15.5
Starting inoculum 10% 11
Starting inoculum 15% 11
Incubation period 2nd day NA
Incubation period 3rd day 12
Incubation period 4th day 15
Incubation period 5th day 18
Incubation period 6th day 19
Incubation period 7th day 19
Incubation period 8th day 20
Incubation period 9th day 21
Incubation period 10th day 22
Incubation period 11th day 25
Incubation period 12th day 23
Incubation period 13th day 22
Incubation period 14th day 21
extracts using the tested concentrations for both cell lines. The
ethyl acetate extract from isolate AGM12-1 exhibited the most
potent effect against both cell lines with IC50 3.3 and 1.1 µg/ml
against HCT 116 and HepG-2 respectively. Moreover, all tested
compounds showed higher cytotoxicity against HepG 2 cell line
compared to HCT 116.
Phenotypic Characterization of AGM12-1
Isolate
The light microscopic observation of AGM12-1 isolate on ISP4
media showed a straight chain section with no fragmentation
of the aerial mycelium. Also SEM observation showed a crimpy
spore surface with aerial and vegetative hyphae which were
well-developed and not fragmented. The other morphological
characters, after growing in different growth media, are
summarized in Table 1. The physiological and biochemical
characters denoted in the production of different enzymes,
utilization of different nitrogen and carbon sources, and ability
to grow at a wide range of pH are illustrated in Table 2. Based on
these morphological and biochemical characteristics of AGM 12-
1, it was presumptively identified as a member of Streptomyces sp.
according to Williams et al. (1983).
Genotypic Characterization of AGM12-1
Isolate and Screening for Antibiotic
Biosynthetic Gene Clusters
The partial 16S rRNA gene sequencing revealed a 99% similarity
with Streptomyces vinaceusdrappus according to NCBI GenBank.
The resulted sequence was aligned to 19 of the closely related
Streptomyces sp. by retrieving their sequences from the NCBI
GenBank database and assembled in MEGA7 software for
phylogenetic analysis using the Neighbor-Joining method and
the evolutionary distances were computed using the Kimura 2-
parameter method. The obtained phylogenetic tree (Figure 3)
confirmed the similarity of the AGM12-1 isolate to Streptomyces
vinaceusdrappus with a similarity matrix bootstrap value of 89.
The GenBank accession number for the partial 16S rRNA gene
sequence of AGM12-1 strain is KY392992.
Screening of Streptomyces sp. AGM12-1 for the presence of
biosynthetic genes involved in the production of glycopeptide
antibiotics (OXY B), NRPS, type I polyketide synthase (PKS
I) and type II polyketide synthase (ARO-PKS II) revealed
the presence of type II polyketide synthase system which is
mostly responsible for the synthesis of aromatic polyketides. In
another study (Busti et al., 2006), they reported the presence of
antibacterial activated genes NRPSs, type I and type II PKSs in
their isolate.
Optimizing the Production of
Antimicrobial Secondary Metabolites
The optimum growth conditions for production of antimicrobial
and antitumor agents from Streptomyces sp. AGM12-1 were
screened and illustrated in Table 3. It was found that the
maximum productivity was achieved after using mannitol
and ammonium sulfate at concentrations of 2.5 and 0.2%,
respectively. Other factors like pH 7, starting inoculum 2%
and incubation for 11 days at 30◦C were found to produce a
high yield of antimicrobial and antitumor substance. In other
studies (Sujatha et al., 2005), it was reported that the glucose
and ammonium nitrate in synthetic media were the optimum
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FIGURE 4 | High performance liquid chromatography (HPLC) chromatograms of a re-purified sample using a Nucleosil C18 column showing the
active compound eluted at 20.32 min (fraction tube number 18).
FIGURE 5 | Nuclear magnetic resonance (NMR) spectrum of antimicrobial and antitumor agent produced by Streptomyces sp. AGM12-1.
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carbon and nitrogen sources to obtain a high yield of antibiotic.
Also (Kadiri and Yarla, 2016) reported that the arabinose and
dextrose were the best carbon sources and L-asparagine was the
best nitrogen source in their study. Pandey et al. (2005) tested
a number of carbon and nitrogen compounds for their effect
on the production of an antibacterial antibiotic by Streptomyces
kanamyceticus M27. It was found dextrose as the most suitable
carbon source while maltose, sucrose, and soluble starch gave
moderate yield. (NH4)H2P04 and yeast extract were adequate
nitrogen sources for antibiotic production. It was found that
media with alkaline pH gave high antibiotic yield.
Purification of the Antimicrobial
Compound and MIC Determination
The active metabolites were extracted with ethyl acetate at
the level of (1:1 v/v) and the separation of the antimicrobial
compound was carried out by HPLC in which 23 fractions
were collected manually and tested for their antimicrobial
activities (Supplementary Figure 1). The active fractions were re-
chromatographed till showing one pure compound at 20 min
(fraction number 18) as seen in Figure 4. MIC values, ranging
from 50 to 0.77 µg/ml, were tested against all indicator
microorganisms by broth-micro dilution method. Lowest MIC
was recorded against Sarcina lutea (6.25 µg/ml) while largest
MIC was recorded against Candida albicans and Escherichia coli
ATCC 8739 (25 µg/ml). For both Staphylococcus aureus ATCC
6538 and Bacillus subtilis, the recorded MIC was 12.5 µg/ml.
Spectroscopic Characteristics
Based on 1HNMR spectrum (Figure 5), molecular mass (m/z
488.05) and comparing the results with previously published
data, the isolated compound was identified as Cyclo (S-Pro-S-
Val) (Figure 6) (Jayatilake et al., 1996). This compound is related
to the diketopiperazine family that has important biological
activities as inhibition of plasminogen activator inhibitor-1 (PAI-
1) (Einholm et al., 2003) and alteration of cardiovascular and
blood-clotting functions (Martins and Carvalho, 2007). They also
have activities as antitumor, antiviral, antifungal, antibacterial,
and antihyperglycaemic (Martins and Carvalho, 2007).
Diketopeprazine is a huge family with variable bioactivities
and about 200 articles had isolated many of these derivatives.
For examples, Wang et al. (2013) reported that five new
diketopiperazine derivatives were isolated from the marine-
derived actinomyces “Streptomyces sp. FXJ7.328.” In another
study, researchers reported that five diketopiperazines
derivatives were isolated from deep-sea bacterium Streptomyces
fungicidicus with a novel antifoulants activity (Li et al.,
2006). Also, Streptomyces globisporus 1912, a producer of
the antitumor antibiotic landomycin E, forms new low molecular
signaling molecule N-methyl phenylalanyl-dehydrobutyrine
diketopiperazine (Matselyukh et al., 2012).
CONCLUSION
Actinomycetes, especially streptomycetes, still an important
source for bioactive compounds that are used for treating
FIGURE 6 | Chemical structure of the identified compound (a
derivative of diketopiperazine) from Streptomyces sp. AGM12-1.
infections, cancer, and many other diseases. The derivative
of diketopiperazine produced by Streptomyces sp. AGM12-
1, isolated from Beni Suef Governorate, Egypt, demonstrated
obvious inhibitory effects against both Gram-positive and Gram-
negative bacteria beside an antifungal activity. Also, an anti-
tumor toxicity against human liver and colon cell lines; HepG
2 and HCT 116 was reported. To our knowledge, this is
the first time to characterize a diketopiperazine derivative as
a secondary metabolite recovered from Streptomyces sp. in
Egypt.
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